+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Prediabetes Market Outlook 2026-2034: Market Size, Share and Growth Analysis- Product Image
Prediabetes Market Outlook 2026-2034: Market Size, Share and Growth Analysis- Product Image
Sale

Prediabetes Market Outlook 2026-2034: Market Size, Share and Growth Analysis

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6243445
UP TO OFF until Jan 01st 2027
Description Jump to:
The Prediabetes Market is estimated at US$9.8 billion in 2026 and is projected to grow at a CAGR of 9.1% to reach US$19.7 billion by 2034.

Market Overview

The Prediabetes Market covers diagnostic, therapeutic, monitoring, and preventive care solutions focused on identifying and managing elevated metabolic risk before diabetes progression. Its value chain includes diagnostic labs, device makers, digital health platforms, clinics, wellness providers, payers, and pharmaceutical participants.

Core applications include screening, lifestyle management, weight control, remote coaching, risk monitoring, and primary care follow up. At the same time, suppliers must respond to low patient awareness, long behavior change timelines, reimbursement gaps, and inconsistent follow up adherence.

Key Companies Analysed

  • Abbott
  • Dexcom
  • Medtronic
  • Roche
  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Bayer
  • Ascensia Diabetes Care
  • LifeScan
  • Omada Health
  • Noom
  • Lark Health
  • Livongo
  • Virta Health
  • WeightWatchers Clinic
  • Merck & Co.
  • Pfizer
  • GSK
  • ResMed

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Prediabetes Market Overview
2.1. Prediabetes Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Prediabetes Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Prediabetes Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Prediabetes Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
6. North America Prediabetes Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Outlook By Country
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
7. Europe Prediabetes Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Outlook By Country
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Poland
7.2.9. Sweden
7.2.10. Russia
8. Asia-Pacific Prediabetes Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Outlook By Country
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Malaysia
8.2.8. Vietnam
9. Middle East and Africa Prediabetes Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Outlook By Country
9.2.1. Saudi Arabia
9.2.2. South Africa
9.2.3. Iran
9.2.4. United Arab Emirates
9.2.5. Egypt
10. South and Central America Prediabetes Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Outlook By Country
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Chile
10.2.4. Peru
11. Prediabetes Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Abbott
11.2.2. Dexcom
11.2.3. Medtronic
11.2.4. Roche
11.2.5. Novo Nordisk
11.2.6. Sanofi
11.2.7. Eli Lilly
11.2.8. Bayer
11.2.9. Ascensia Diabetes Care
11.2.10. LifeScan
11.2.11. Omada Health
11.2.12. Noom
11.2.13. Lark Health
11.2.14. Livongo
11.2.15. Virta Health
11.2.16. WeightWatchers Clinic
11.2.17. Merck & Co.
11.2.18. Pfizer
11.2.19. GSK
11.2.20. ResMed
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Abbott
  • Dexcom
  • Medtronic
  • Roche
  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Bayer
  • Ascensia Diabetes Care
  • LifeScan
  • Omada Health
  • Noom
  • Lark Health
  • Livongo
  • Virta Health
  • WeightWatchers Clinic
  • Merck & Co.
  • Pfizer
  • GSK
  • ResMed

Table Information

Report AttributeDetails
No. of Pages160
PublishedOctober 2026
Forecast Period2026 - 2034
Estimated Market Value ( USD ) in 2026 $ 9.8 Billion
Forecasted Market Value ( USD ) by 2034 $ 19.7 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Prediabetes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Prediabetes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Prediabetes - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Prediabetes - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Prediabetes Epidemiology Forecast 2026-2035 - Product Image

Prediabetes Epidemiology Forecast 2026-2035

  • Report
  • 100 Pages
  • Global
From
Pandemic of Diabetes and Prediabetes: Prevention and Control, An Issue of Endocrinology and Metabolism Clinics of North America. The Clinics: Internal Medicine Volume 50-3 - Product Image

Pandemic of Diabetes and Prediabetes: Prevention and Control, An Issue of Endocrinology and Metabolism Clinics of North America. The Clinics: Internal Medicine Volume 50-3

  • Book
  • North America
Cardiovascular Outcomes of Treatments available for Patients with Type 1 and 2 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America. The Clinics: Internal Medicine Volume 47-1 - Product Image

Cardiovascular Outcomes of Treatments available for Patients with Type 1 and 2 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America. The Clinics: Internal Medicine Volume 47-1

  • Book
  • North America
Copyright © 2002-2026 Research and Markets. All Rights Reserved.